Replies to post #2389 on InVivo Therapeutics Holdings Corp (NVIVQ)

[Halks1122]

I'm thinking $3. Are they still trying to be uplisted?

[mikeysox21]

I believe it should follow ICPT if the results are positive. As to your point a week after the first Pt is announced I see it hovering around the high 2s to low 3s. Either way hopefully it's positive and can better peoples lives. GLTA

[errett]

NVIV---I don't think the pps will improve much on the announcement of the first patient being treated----we won't have results for three months-----if the first patient has no complications, and in addition shows improvement in kind as we have witnessed in the monkey trials, then my WAG on price would be between $3-$7-----I think the second patient is the big one----and that would be at six months out since the patients are sequential in treatment-----if number two is good then we have a major move---any number is just an obvious wish/guess but probably to the mid teens or higher. glta jmo

Number of Subjects: 5 (staged enrollment w/ 3 mth wait between Subjects to monitor safety and resorption) ? Number of Sites: up to 6

? Key Inclusion Criteria
1.Aged 18 – 55 years
2.ASIA A traumatic spinal cord injury (T3-T11) confirmed by neurosurgeon, occurring within past 10 days
3.Non-penetrating contusion injury no less than 4 mm diameter and limited to 2 contiguous vertebral levels

? Key Exclusion Criteria
1.Incomplete spinal cord injury (ASIA B, C, D, E)
2.Terminally ill
3.Significant spinal conditions other than lesion to be treated
4.Spinal cord injury associated with traumatic brain injury
5.Subject on long term mechanical ventilation
6.Penetrating injuries
7.Radiographic evidence of parenchymal disassociation or anatomic transection where the contusion completely bridges a full cross-section of the spinal cord